This year CPhI & P-MEC China returns as a SMART event, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. […]

Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients As investment in gene therapies continues to grow rapidly, more effectively engaging patients […]

SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA SESSING DEVICE DEVELOPMENT AND REGULATION FOR ADVANCED INNOVATION SMi is delighted to […]

Outcomes for HER2-expressing breast cancer are patients constantly improving; advancements in diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 ‘low' space […]

Returning in 2022, the 2nd Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. This is your ultimate forum to identify, validate, and […]

Biotech companies are paving the way to displace the cochlear implant and cater for the huge unmet need in hearing and balance disorders. The field is booming with excitement, with […]

CPhI & P-MEC China is Asia's leading pharmaceutical show for trading, knowledge sharing and networking. It spans all industry sectors along the pharmaceutical supply chain and is your one-stop platform […]

The 7th Microbiome Movement - Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this […]

Built with biopharmaceutical industry insights, this in-person conference will delve into the latest advancements of non-viral RNA delivery systems such as LNPs, exosomes and polymers to set the scene for […]

Are you using TCRs to target solid tumors yet? With Immunocore having achieved commercialization for the first TCR therapy and Adaptimmune hot on their tail, 2022 is fast becoming the […]

Undoubtedly, the past two years have changed the pharma industry forever; new modalities are dominating pharma pipelines, drugs are increasing in potency, and the restrictions around product quality are tighter […]

The 8th Annual Microbiome Connect: Europe 2022 dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia, engineered microbes, and microbial-derived metabolites for therapeutic and […]

Accelerating Europe's Progress in CNS Gene Therapy Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the […]

The Digital Biomarkers & Clinical Measures in Neurology Summit is the definitive industry forum sharing cross-industry insight to transform clinical development with digital data. From integrating wearable technologies, smartphone apps, and speech-based […]

Migrate Your GxP Regulated Applications to the Cloud with Compliance, Security, & Quality Assurance  With hot anticipation for the FDA’s new CSA guidance, life science companies have the opportunity to […]

With the undeniable excitement in the BCMA field over the past few months, the BCMA-Targeted Therapies Summit returns to the space to equip you with the knowledge and connections to […]

The Advanced Wound Care Innovation Summit is the first industry-led forum focused on delivering innovative wound care treatments to patients. Expect to hear from, and discuss with, world leaders of wound care research who […]

The RNA Therapeutic Modalities Summit is North America’s only industry led conference covering clinical progress and commercial scale development for the full spectrum of RNA therapeutic approaches. Our agenda will […]

Overcome First Generation Gene Therapy Vector Challenges To Guarantee Targeted, Specific, Efficient & Safe Gene Delivery The 2nd Next Generation Gene Therapy Vectors Summit is dedicated to overcoming the current […]

LEAP HR: Life Sciences East 2022 Conference will be taking place as an in-person event in Boston, July 18-20. Returning as a physical event for its seventh year, this event […]

Cell Therapy Potency Assay Summit, taking place from 25-27 of July in Boston, will bring together professionals working in analytical development, quality, regulatory and process development functions. Join your peers […]

The data has dropped and 2022 has been touted as a monumental year for γδT Therapies With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical […]

The 3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit is the only industry-led forum focused on the therapeutic opportunity of drugs directed against B-cell, plasma cell, and […]

The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field. With 30+ expert speakers, including the hottest academic researchers and leading figures […]

Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28. Expect exclusive data from the movers and shakers in mRNA vaccine and […]

With iPSCs exhibiting game-changing potential in the bid to develop an off-the-shelf therapy, the brand-new iPSC Manufacturing Summit is the only summit dedicated to solving the manufacturing, quality and analytical challenges hindering […]

The brand-new Targeted Radiopharmaceuticals Summit US (TRP US) is the only industry-led meeting dedicated to developing next-generation radioligands. The TRP sector has developed dramatically over the previous 18 months, with […]

Cell Therapy Analytical Development Summit Europe, taking place from 23-25 of August in London, will bring together professionals working in CMC, QC, process development, and regulatory functions. Join your peers […]

With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has […]

Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug […]